Clinical Trials Logo

Clinical Trial Summary

Family members of critically ill (ICU) patients are at risk for developing significant symptoms of anxiety, depression, and post-traumatic stress during and after the ICU experience. Cognitive behavioral therapy is a form of therapy that can help individuals cope with stressful events in a more active and effective way. This study will examine the effectiveness of a smartphone self-care app delivering cognitive behavioral therapy in decreasing the psychological symptoms suffered by ICU family members. Half of the sample will receive the self-care app and half of the study sample will receive the usual supportive care given to family members of ICU patients. The researchers anticipate the self-care app will diminish the severity of anxiety, depression, and post-traumatic stress symptoms experienced by ICU family members.


Clinical Trial Description

Family members of critically ill patients suffer symptoms of post-intensive care syndrome-family (PICS-F), including anxiety, depression, and post-traumatic stress disorder with a diminished quality of life. These symptoms persist long after the episode of critical illness and can linger for years. Cognitive behavioral therapy has become the primary non-pharmacological treatment of an increasing list of psychological symptoms and disorders, including anxiety, depression, and post-traumatic stress. For mild-to-moderate symptoms, mobile technology delivery of cognitive behavioral therapy without input from a clinician has been found to be feasible and well-accepted with efficacy that rivals face-to-face therapy.

The purpose of this pilot study is to examine the efficacy of smartphone delivery of cognitive behavioral therapy via a mobile health app (intervention) on the severity and prevalence of PICS-F symptoms in family members of critically ill patients. The study will include family members of critically ill patients admitted to two 26-bed ICUs at the Akron campus of Summa Health System. A prospective, repeated measures, longitudinal design with randomization to two groups (control, intervention) will be employed. Primary outcome measures will include symptoms of PICS-F (anxiety, depression, post-traumatic stress), health-related quality of life, and mental health self-efficacy measured at enrollment, 30 days after enrollment, and 60 days after enrollment. App usage over the course of the study (number of logins, total time spent with app) will be obtained at the final time point of the study (60 days after enrollment). A sample size of 60 family members is planned for this pilot study (30 intervention, 30 control). The sample size was determined according to the recommendations of Whitehead et al.estimating an a priori small effect size and an attrition rate of 30% derived from previous studies.

The aims of the study are:

Aim 1: Determine the prevalence and severity of PICS-F symptoms (anxiety, depression, post-traumatic stress), health-related quality of life (HRQOL), and mental health self-efficacy (MHSE) in family decision makers of critically ill patients and their change over time (enrollment, 30 days, 60 days).

Aim 2: Determine differences in PICS-F symptom severity, HRQOL, and MHSE in family decision makers of critically ill patients receiving a mobile health app (MHapp) intervention compared to family members receiving standard care and support.

Aim 3: Determine the relationship between the dose of the MHapp (total time spent with the app, total log-ins) over the course of the study (60 days) and changes in PICS-F symptom severity (anxiety, depression, post-traumatic stress), HRQOL, and MHSE.

Data Analysis and Statistical Plan: Data will be analyzed using Statistics Package for the Social Sciences (SPSS, Version 25) software. Descriptive statistics will be used to assess frequencies and variability of the data, coding inaccuracies, outliers, and missing data. The statistical plan for each specific aim is as follows:

Aim 1: The investigators will report study variables with descriptive statistics. Change over time will be examined with repeated measures ANOVA.

Aim 2: Differences between intervention and control groups will be assessed with student's t-test. Differences between groups in regard to severity of PICS-F symptoms will be used to calculate effect size for the intervention.

Aim 3: Relationship between total MHapp dose and longitudinal change in study variables will be examined with Pearson's correlation.

Human Subjects and Ethical Issues: The research presents no more than minimal psychological risk or harm, largely from the possibility that answering the questions on the anxiety, depression, and stress instruments may be distressing for participants. Psychological risk will be minimized by emphasizing that study participants can stop participating in the study at any time and are not obligated to answer any question that they find distressing. Family members who endorse clinically significant symptoms will be referred to their primary care physician. Family members of patients who die during the study will be referred to local bereavement support groups.

There is a low risk of privacy or confidentiality loss. Risk will be minimized by the following measures: (a) the only record linking the participant and the research data is the consent document; (b) consent documents will be kept in a locked cabinet in the locked office of the PI; (c) data will be entered and stored by the RA on REDCap, a secure, HIPAA-compliant web-based platform; (d) all data files obtained for analysis will be stored on a password-protected laptop computer stored in a locked room; and (e) The PI, co-investigators, and research assistant (RA) are the only individuals with access to the data files. ;


Study Design


Related Conditions & MeSH terms

  • Post Intensive Care Unit Syndrome
  • Syndrome

NCT number NCT04316767
Study type Interventional
Source Kent State University
Contact Amy B Petrinec, PhD
Phone 330-715-2987
Email apetrine@kent.edu
Status Recruiting
Phase N/A
Start date August 28, 2020
Completion date January 2022

See also
  Status Clinical Trial Phase
Completed NCT04601090 - Survival Rates and Longterm Outcomes After COVID-19
Completed NCT04501445 - Psychological Symptoms and Families of COVID-19 Patients N/A
Recruiting NCT05182086 - Improving Recovery After Critical Illness N/A
Recruiting NCT05537298 - Muscle Recovery After Critical Illness
Completed NCT04194229 - Cytoflavin in the Rehabilitation of Post-intensive Care Syndrome in Stroke Survivors
Active, not recruiting NCT06119711 - Micronutrient Levels and Nutritional Status in Critical Illness
Completed NCT04154995 - Intensive Care Unit Recovery
Completed NCT04412330 - Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 N/A
Completed NCT04476914 - Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU
Recruiting NCT04608994 - Long-term Follow up in Survivors of Critical Illness
Completed NCT04422444 - Post Intensive Care Syndrome in COVID19 Patients
Completed NCT05537311 - Reducing Isolation and Feeling of Loneliness During Critical Illness N/A
Recruiting NCT04967365 - Post-Intensive Care Syndrome - Pediatrics (PICS-p): Longitudinal Cohort Study
Recruiting NCT04163497 - ICU Diaries and Its Effects After the Unit Discharge N/A
Active, not recruiting NCT04317144 - Web-based Follow-up to Former ICU Patients N/A
Recruiting NCT06019078 - pEEG Monitoring Effect on Delirium, Ventilator Days, and PICS
Terminated NCT04175717 - Feasibility of a Physiotherapy-led Follow-up Programme in Adult Critical Illness Survivors N/A
Active, not recruiting NCT04637113 - Singapore's Health Outcomes After Critical Illness in Kids
Active, not recruiting NCT04099472 - Partnering With Family Members to Prevent, Detect and Manage Delirium in Critically Ill Patients. N/A
Completed NCT04940208 - Chronic Pain in COVID-19 Patients Discharged From Intensive Care Unit